Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Sex-specific effects of prenatal valproic acid exposure on sociability and neuroinflammation: Relevance for susceptibility and resilience in autism.

Kazlauskas N, Seiffe A, Campolongo M, Zappala C, Depino AM.

Psychoneuroendocrinology. 2019 Dec;110:104441. doi: 10.1016/j.psyneuen.2019.104441. Epub 2019 Sep 11.

PMID:
31541913
2.

Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry.

Jo HE, Corte TJ, Glaspole I, Grainge C, Hopkins PMA, Moodley Y, Reynolds PN, Chapman S, Walters EH, Zappala C, Allan H, Keir GJ, Cooper WA, Mahar AM, Ellis S, Macansh S, Goh NS.

BMC Pulm Med. 2019 May 3;19(1):84. doi: 10.1186/s12890-019-0846-2.

3.

Eligibility for anti-fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testing.

Burgess A, Goon K, Brannan JD, Attia J, Palazzi K, Oldmeadow C, Corte TJ, Glaspole I, Goh N, Keir G, Allan H, Chapman S, Cooper W, Ellis S, Hopkins P, Moodley Y, Reynolds P, Zappala C, Macansh S, Grainge C.

Respirology. 2019 Oct;24(10):988-995. doi: 10.1111/resp.13540. Epub 2019 Mar 28.

4.

Rapid emergence of cryptococcal fungemia, Mycobacterium chelonae vertebral osteomyelitis and gastro intestinal stromal tumor in a young HIV late presenter: a case report.

Marino A, Caltabiano E, Zagami A, Onorante A, Zappalà C, Locatelli ME, Pampaloni A, Scuderi D, Bruno R, Cacopardo B.

BMC Infect Dis. 2018 Dec 27;18(1):693. doi: 10.1186/s12879-018-3573-z.

5.

Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis Registry.

Jo HE, Glaspole I, Goh N, Hopkins PMA, Moodley Y, Reynolds PN, Chapman S, Walters EH, Zappala C, Allan H, Macansh S, Grainge C, Keir GJ, Hayen A, Henderson D, Klebe S, Heinze SB, Miller A, Rouse HC, Duhig E, Cooper WA, Mahar AM, Ellis S, McCormack SR, Ng B, Godbolt DB, Corte TJ.

Respirology. 2019 Apr;24(4):361-368. doi: 10.1111/resp.13427. Epub 2018 Oct 17.

6.

Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry.

Jo HE, Glaspole I, Moodley Y, Chapman S, Ellis S, Goh N, Hopkins P, Keir G, Mahar A, Cooper W, Reynolds P, Haydn Walters E, Zappala C, Grainge C, Allan H, Macansh S, Corte TJ.

BMC Pulm Med. 2018 Jan 25;18(1):19. doi: 10.1186/s12890-018-0575-y.

7.

Determinants and outcomes of prolonged anxiety and depression in idiopathic pulmonary fibrosis.

Glaspole IN, Watson AL, Allan H, Chapman S, Cooper WA, Corte TJ, Ellis S, Grainge C, Goh N, Hopkins P, Keir G, Macansh S, Mahar A, Moodley Y, Reynolds PN, Ryerson CJ, Walters EH, Zappala CJ, Holland AE.

Eur Respir J. 2017 Aug 17;50(2). pii: 1700168. doi: 10.1183/13993003.00168-2017. Print 2017 Aug. No abstract available.

8.

Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry.

Jo HE, Glaspole I, Grainge C, Goh N, Hopkins PM, Moodley Y, Reynolds PN, Chapman S, Walters EH, Zappala C, Allan H, Keir GJ, Hayen A, Cooper WA, Mahar AM, Ellis S, Macansh S, Corte TJ.

Eur Respir J. 2017 Feb 23;49(2). pii: 1601592. doi: 10.1183/13993003.01592-2016. Print 2017 Feb. Erratum in: Eur Respir J. 2017 Mar 29;49(3):.

9.

Health-related quality of life in idiopathic pulmonary fibrosis: Data from the Australian IPF Registry.

Glaspole IN, Chapman SA, Cooper WA, Ellis SJ, Goh NS, Hopkins PM, Macansh S, Mahar A, Moodley YP, Paul E, Reynolds PN, Walters EH, Zappala CJ, Corte TJ.

Respirology. 2017 Jul;22(5):950-956. doi: 10.1111/resp.12989. Epub 2017 Feb 6.

10.

Postnatal behavioral and inflammatory alterations in female pups prenatally exposed to valproic acid.

Kazlauskas N, Campolongo M, Lucchina L, Zappala C, Depino AM.

Psychoneuroendocrinology. 2016 Oct;72:11-21. doi: 10.1016/j.psyneuen.2016.06.001. Epub 2016 Jun 7.

PMID:
27337090
11.

Nurse endoscopy in Australia.

Forbes MP, Manoharan B, Zappala C.

Intern Med J. 2016 Apr;46(4):508-9. doi: 10.1111/imj.13026. No abstract available.

PMID:
27062211
12.

Australian Idiopathic Pulmonary Fibrosis Registry: vital lessons from a national prospective collaborative project.

Moodley Y, Goh N, Glaspole I, Macansh S, Walters EH, Chapman S, Hopkins P, Reynolds PN, Zappala C, Cooper W, Mahar A, Ellis S, McCormack S, Darbishire W, Wood-Baker R, Corte TJ; Australian IPF Registry Steering Committee.

Respirology. 2014 Oct;19(7):1088-91. doi: 10.1111/resp.12358. Epub 2014 Aug 14.

13.

Prevalence and prognosis of unclassifiable interstitial lung disease.

Troy L, Glaspole I, Goh N, Zappala C, Hopkins P, Wilsher M, Moodley Y, Corte T.

Eur Respir J. 2014 May;43(5):1529-30. doi: 10.1183/09031936.00003414. No abstract available.

14.

Predicting pulmonary fibrosis disease course from past trends in pulmonary function.

Schmidt SL, Tayob N, Han MK, Zappala C, Kervitsky D, Murray S, Wells AU, Brown KK, Martinez FJ, Flaherty KR.

Chest. 2014 Mar 1;145(3):579-585. doi: 10.1378/chest.13-0844.

15.

Accuracy of individual variables in the monitoring of long-term change in pulmonary sarcoidosis as judged by serial high-resolution CT scan data.

Zappala CJ, Desai SR, Copley SJ, Spagnolo P, Sen D, Alam SM, du Bois RM, Hansell DM, Wells AU.

Chest. 2014 Jan;145(1):101-107. doi: 10.1378/chest.12-2479.

PMID:
24051950
16.

Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis.

De Lauretis A, Sestini P, Pantelidis P, Hoyles R, Hansell DM, Goh NS, Zappala CJ, Visca D, Maher TM, Denton CP, Ong VH, Abraham DJ, Kelleher P, Hector L, Wells AU, Renzoni EA.

J Rheumatol. 2013 Apr;40(4):435-46. doi: 10.3899/jrheum.120725. Epub 2013 Feb 1.

PMID:
23378460
17.

Idiopathic pulmonary fibrosis: is all-cause mortality a practical and realistic end-point for clinical trials?

Corte TJ, Goh NS, Glaspole IN, Zappala CJ, Hopkins PM, Wilsher ML.

Thorax. 2013 May;68(5):491-2. doi: 10.1136/thoraxjnl-2012-203114. Epub 2013 Jan 23. No abstract available.

PMID:
23345573
18.

Aetiology and clinical phenotype still seem distant in sarcoidosis.

Zappala C, Wells A.

Respirology. 2012 Feb;17(2):199-200. doi: 10.1111/j.1440-1843.2011.02120.x. No abstract available.

PMID:
22221933
19.

Optimal scoring of serial change on chest radiography in sarcoidosis.

Zappala CJ, Desai SR, Copley SJ, Spagnolo R, Cramer D, Sen D, Alam SM, du Bois RM, Hansell DM, Wells AU.

Sarcoidosis Vasc Diffuse Lung Dis. 2011 Oct;28(2):130-8.

PMID:
22117504
20.

Significance of connective tissue disease features in idiopathic interstitial pneumonia.

Corte TJ, Copley SJ, Desai SR, Zappala CJ, Hansell DM, Nicholson AG, Colby TV, Renzoni E, Maher TM, Wells AU.

Eur Respir J. 2012 Mar;39(3):661-8. doi: 10.1183/09031936.00174910. Epub 2011 Sep 15.

21.

Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis.

Zappala CJ, Latsi PI, Nicholson AG, Colby TV, Cramer D, Renzoni EA, Hansell DM, du Bois RM, Wells AU.

Eur Respir J. 2010 Apr;35(4):830-6. doi: 10.1183/09031936.00155108. Epub 2009 Oct 19.

22.

The antimicrobial effect of heparin on common respiratory pathogens.

Zappala C, Chandan S, George N, Faoagali J, Boots RJ.

Crit Care Resusc. 2007 Jun;9(2):157-60.

PMID:
17536984
23.

Hemorrhagic peritoneal carcinomatosis treated with a weekly schedule of carboplatin and paclitaxel. A case report.

Montella L, Vardanega A, Perin B, Zappalà C, Bonciarelli G.

Tumori. 2003 May-Jun;89(3):336-9.

PMID:
12908796
24.

Eosinophilic ileocolitis by Enterobius vermicularis: a description of two rare cases.

Cacopardo B, Onorante A, Nigro L, Patamia I, Tosto S, Romano F, Zappalà C, Bruno S, Nunnari A.

Ital J Gastroenterol Hepatol. 1997 Feb;29(1):51-3.

PMID:
9265579
25.

Hemophagocytic syndrome in a case of splenic large B-cell lymphoma.

Büchi G, Termine G, Orlassino R, Pagliarino M, Boero R, Zappalà C, Grosso E.

Tumori. 1996 Nov-Dec;82(6):621-4.

PMID:
9061078
26.

Microstructural aspects of the Captek alloy for porcelain-fused-to-metal restorations.

Zappala C, Shoher I, Battaini P.

J Esthet Dent. 1996;8(4):151-6. No abstract available.

PMID:
9468835
27.

2-(4-Pyridyl)-delta 2-1,3,4-oxadiazolines from isonicotinoylhydrazones and diazomethane as potential antimycobacterial and anti-HIV agents. V.

Vigorita MG, Ottanà R, Zappalà C, Maccari R, Pizzimenti FC, Gabbrielli G.

Farmaco. 1995 Nov;50(11):783-6.

PMID:
8593176
28.

Halogenated isoniazid derivatives as possible antimycobacterial and anti-HIV agents--III.

Vigorita MG, Ottanà R, Zappalà C, Maccari R, Pizzimenti FC, Gabbrielli G.

Farmaco. 1994 Dec;49(12):775-81.

PMID:
7893334
29.

Options in aesthetic restorations: discoloration and malformation--problems and solutions.

Zappala C, Bichacho N, Prosper L.

Pract Periodontics Aesthet Dent. 1994 Oct;6(8):43-51; quiz 52. Review.

PMID:
7662949
30.

3,3'-Bi-[1,3-thiazolidine-4-one] system. VII. Synthesis and SARS of some 2-heteroaryl derivatives with antiinflammatory and related activities.

Previtera T, Vigorita MG, Fenech G, Zappala C, Giordano A, Monforte MT, Forestieri AM.

Farmaco. 1994 Jan;49(1):33-40.

PMID:
8185747
31.

Halogenated isoniazid derivatives as possible antitubercular and antineoplastic agents. Note 1.

Vigorita MG, Basile M, Zappalà C, Gabbrielli G, Pizzimenti F.

Farmaco. 1992 Jun;47(6):893-906.

PMID:
1388607
32.

N-trifluoroacetyl derivatives as pharmacological agents. V. Evaluation of antiinflammatory and antimicrobial activities of some N-heterocyclic trifluoroacetamides.

Vigorita MG, Previtera T, Zappalà C, Trovato A, Monforte MT, Barbera R, Pizzimenti F.

Farmaco. 1990 Feb;45(2):223-35.

PMID:
2133997
33.

Differentiation phenotypes on cells of acute myeloid leukemia studied by My7, My9, My4, Mo1 and Ja monoclonal antibodies.

Büchi G, Girotto M, Baldini G, Grosso E, Termine G, Gario S, Autino R, Zappalà C, Ganio D.

Pathologica. 1987 Nov-Dec;79(1064):699-704. No abstract available.

PMID:
3503228
34.

A case of refractory anemia with excess of blasts evolving to acute myelomonocytic leukemia studied with monoclonal antibodies.

Büchi G, Girotto M, Termine G, Ganio D, Gario S, Grosso E, Autino R, Zappalà C.

Haematologica. 1987 Sep-Oct;72(5):455-7. No abstract available.

PMID:
3121469
35.

Alterations due to ampicillin and rifampicin in S. sanguis and S. aureus isolated from dental plaque. An electron microscopic study.

Filice G, Carnevale G, Lanzarini P, Castelli F, Zappalà C, Menghini P, De Rysky C.

Chemioterapia. 1986 Feb;5(1):3-6.

PMID:
3955780
36.

B and T lymphocytic populations and subpopulations and natural killer cells (NK) in blood of patients with myeloma and with monoclonal gammopathy of undetermined significance (MGUS).

Büchi G, Girotto M, Termine G, Gario S, Grosso E, Autino R, Zappalà C.

Pathologica. 1985 Jul-Aug;77(1050):385-93. No abstract available.

PMID:
3879633
37.

Lymphocyte populations and T cell subpopulations in blood of patients with non-Hodgkin lymphomas.

Büchi G, Girotto M, Termine G, Gario S, Grosso E, Autino R, Zappalà C, Ferrero I.

Acta Haematol. 1984;71(5):322-8.

PMID:
6429998
38.

Spontaneous complete remission of CLL. Report of a case studied with monoclonal antibodies.

Büchi G, Termine G, Zappalà C, Girotto M, Grosso E, Autino R.

Acta Haematol. 1983;70(3):198-201.

PMID:
6224388
39.

Chemotherapy of advanced non-Hodgkin lymphomas: a report of 35 cases.

Büchi G, Mazza U, Camaschella C, Saglio G, Cambrin GR, Termine G, Enrico E, Autino R, Zappala C.

Tumori. 1982 Aug;68(4):307-11.

PMID:
6897306
40.

[Factors influencing the changes in liver melanin content of amphibia. I. Effect of breeding temperature].

Corsaro C, Capodicasa V, Carcò D, Cristaldi G, Zappalà C.

Boll Soc Ital Biol Sper. 1979 May 30;55(10):1008-14. Italian.

PMID:
315778
41.

[Changes in the melanin content in the Kupffer cells of Rana esculenta L., induced by parenteral administration of heme].

Cicero R, Scalia M, Sinatra F, Zappalà C.

Boll Soc Ital Biol Sper. 1977 May 15;53(9):764-9. Italian. No abstract available.

PMID:
303113
42.

[PRELIMINARY RESEARCH WITH GASTRIC BIOPSY IN CARDIAC PATIENTS WITH MANIFESTATIONS OF CONGESTIVE INSUFFICIENCY OF THE GREATER CIRCULATION].

GAGLIO M, ZAPPALA C, AMARO A.

Boll Soc Ital Cardiol. 1963;8:389-95. Italian. No abstract available.

PMID:
14122352

Supplemental Content

Loading ...
Support Center